Doctor of Optometry Program year 2025 Reported 2022–2025 Source: CMS Open Payments, 2026 publication

Allison Zagst

Optometrist Saint Louis, MO Doctor of Optometry

NPI 1184357949 CMS profile 11320411

7840 Natural Bridge Rd, Saint Louis, MO 63121

Open in the dashboard

General payments

$3,944

63 records reported · program years 2022–2025

Research payments

$0

Paid to them · None reported · program years 2022–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Allison Zagst of Saint Louis, MO is reported in the CMS Open Payments database as having received $3,944 across 63 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 90th percentile of Optometrist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $205 3
2024 General $140 2
2023 General $931 24
2022 General $2,668 34

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Allison Zagst
  • Optometrist median
  • Middle half of Optometrist
  • National median

In program year 2025, general payments to Allison Zagst were reported at $205. Among 35,373 Optometrist profiles paid that year, the median was $204 and the middle half received between $87 and $464.

Show as a table
Year Allison Zagst Optometrist median Middle half National median
2019 $0 $159 $67–$371 $163
2020 $0 $72 $29–$165 $114
2021 $0 $125 $46–$292 $132
2022 $2,668 $162 $66–$374 $149
2023 $931 $177 $72–$406 $160
2024 $140 $188 $77–$427 $164
2025 $205 $204 $87–$464 $169

Breakdown

Who paid General payments · program years 2022–2025
  1. Bausch & Lomb Americas Inc. $2,277 25 payments
  2. Alcon Vision LLC $546 12 payments
  3. Johnson & Johnson Vision Care, Inc. $502 9 payments
  4. CooperVision Inc. $294 5 payments
  5. AbbVie, Inc. $118 6 payments
  6. Horizon Therapeutics plc $98 1 payment
  7. Carl Zeiss Meditec, Inc. $33 1 payment
  8. Astellas Pharma US Inc $29 1 payment
  9. Oyster Point Pharma, Inc. $17 1 payment
  10. Carl Zeiss Meditec USA, Inc. $15 1 payment
  11. Other $15 1 payment

Every payment, record by record

What the payments were for General payments · program years 2022–2025
  1. Food and Beverage $1,618 52 payments
  2. Travel and Lodging $1,451 6 payments
  3. Consulting Fee $525 3 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $350 2 payments
Products named General payments · program years 2022–2025
  1. INFUSE $2,068 22 payments
  2. MULTI-FOCAL LENS $1,803 15 payments
  3. ZEN LENS $1,803 15 payments
  4. Acuvue $502 9 payments
  5. AIR OPTIX $365 5 payments
  6. Clariti Contact Lens $181 2 payments
  7. TOTAL30 $148 5 payments
  8. Precision 1 $125 3 payments
  9. ULTRA MULTIFOCAL TORIC $123 1 payment
  10. TEPEZZA $98 1 payment
  11. Other $501 20 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

63 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Optometrist in Missouri

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record